Kazam Joshua A - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 18, 2025, Kazam Joshua A's relationship to Allogene Therapeutics, Inc. (ALLO) is Director, and currently has 350,763 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ALLO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kazam Joshua A - Insider Non-Derivative Transactions of ALLO Common Stock

Kazam Joshua A - Insider Non-Derivative Transactions at ALLO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2025	M -- (Common Stock)	47700	0	350763